Literature DB >> 19034478

Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells.

Gabriele Thumann1, Anna Katharina Salz, Peter Walter, Sandra Johnen.   

Abstract

PURPOSE: To examine whether iris pigment epithelial (IPE) cells transplanted into the subretinal space of Royal College of Surgeons (RCS) rats have the ability to rescue photoreceptors.
METHODS: Rat IPE (rIPE) or human IPE (hIPE) cells were transplanted subretinally in 23-day-old RCS rats. Sham injection and transplantation of ARPE-19 cells served as controls. After 12 weeks, eyes were evaluated for photoreceptor survival by morphometric analysis and electron microscopy.
RESULTS: Morphometric analysis showed photoreceptor rescue in all transplanted and sham-injected animals (number of photoreceptors/300 microm retina+/-sd: rIPE 41.67 +/- 28; hIPE 29.50 +/- 16; ARPE-19 36.12 +/- 21; sham 16.56 +/- 6) compared to age-matched, control rats (number of photoreceptors/300 microm retina+/-sd: 9.71 +/- 4). Photoreceptor rescue was prominent in IPE cell-transplanted rats and was significantly greater than sham-injected eyes (p = 0.02 for rIPE and p = 0.04 for hIPE).
CONCLUSION: Since IPE cells transplanted into the subretinal space have the ability to rescue photoreceptors from degeneration in the RCS rat without any harmful effects, IPE cells may represent an ideal cell to genetically modify and thus carry essential genetic information for the repair of defects in the subretinal space.

Entities:  

Mesh:

Year:  2008        PMID: 19034478     DOI: 10.1007/s00417-008-0998-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  49 in total

1.  Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy.

Authors:  Hiroko Terasaki; Yozo Miyake; Toshimitsu Suzuki; Takashi Niwa; Chang-Hua Piao; Satoshi Suzuki; Makoto Nakamura; Mineo Kondo
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

Review 2.  Photoreceptor rescue in the dystrophic retina by transplantation of retinal pigment epithelium.

Authors:  H J Sheedlo; L Li; V P Gaur; R W Young; A D Seaton; S V Stovall; C D Jaynes; J E Turner
Journal:  Int Rev Cytol       Date:  1992

3.  Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results.

Authors:  Alexandra Lappas; Andreas M H Foerster; Andreas W A Weinberger; Silke Coburger; Norbert F Schrage; Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-06       Impact factor: 3.117

4.  Graft location affects functional rescue following RPE cell transplantation in the RCS rat.

Authors:  H Klassen; S J Whiteley; M J Young; R D Lund
Journal:  Exp Neurol       Date:  2001-05       Impact factor: 5.330

5.  Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration.

Authors:  C Eckardt; U Eckardt; H G Conrad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-04       Impact factor: 3.117

6.  Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa.

Authors:  Laura Lenzi; Marco Coassin; Alessandro Lambiase; Stefano Bonini; Tiziana Amendola; Luigi Aloe
Journal:  Vision Res       Date:  2005-06       Impact factor: 1.886

7.  Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats.

Authors:  Tsutomu Sakai; Noriyuki Kuno; Fumihiko Takamatsu; Erika Kimura; Hideo Kohno; Kiichiro Okano; Kenji Kitahara
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

8.  Transplanted retinal pigment epithelium modifies the retinal degeneration in the RCS rat.

Authors:  R Lopez; P Gouras; H Kjeldbye; B Sullivan; V Reppucci; M Brittis; F Wapner; E Goluboff
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-03       Impact factor: 4.799

9.  Rod outer segment maintenance is enhanced in the presence of bFGF, CNTF and GDNF.

Authors:  M E Carwile; R B Culbert; R L Sturdivant; T W Kraft
Journal:  Exp Eye Res       Date:  1998-06       Impact factor: 3.467

10.  The effects of bFGF on RCS rat eyes.

Authors:  J Perry; J Du; H Kjeldbye; P Gouras
Journal:  Curr Eye Res       Date:  1995-07       Impact factor: 2.424

View more
  7 in total

Review 1.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

2.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

Review 3.  Ophthalmic transplantology: posterior segment of the eye--part II.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-06

Review 4.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

5.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

6.  Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies.

Authors:  Marina Riera; Laura Fontrodona; Silvia Albert; Diana Mora Ramirez; Anna Seriola; Anna Salas; Yolanda Muñoz; David Ramos; Maria Paz Villegas-Perez; Miguel Angel Zapata; Angel Raya; Jesus Ruberte; Anna Veiga; Jose Garcia-Arumi
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

7.  Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization.

Authors:  Maria Hernandez; Sergio Recalde; Laura Garcia-Garcia; Jaione Bezunartea; Csaba Miskey; Sandra Johnen; Sabine Diarra; Attila Sebe; Juan Roberto Rodriguez-Madoz; Severine Pouillot; Corinne Marie; Zsuzsanna Izsvák; Daniel Scherman; Martina Kropp; Felipe Prosper; Gabriele Thumann; Zoltán Ivics; Alfredo Garcia-Layana; Patricia Fernandez-Robredo
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-09       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.